Register to receive a free US Market Report Suite for Dialysis Device and Concentrates report synopsis and brochure

According to a new series of reports on the U.S. market for dialysis devices and concentrates by iData Research, the industry has been slow to transition away from in-center hemodialysis treatments. The reassurance and safety of having trained professionals available has been a strong incentive for patients to choose in-center treatments. Additionally, despite the increasing number of patients requiring dialysis, many are not eligible for at-home treatment options.

The Centers for Medicare and Medicaid Services (CMS) announced a plan to cut funding for dialysis treatments by 9.4%, or approximately $970 million. These decreases in reimbursement have had a significant impact on the markets for dialysis equipment. These reductions to reimbursement limit the growth of dialysis device and concentrate markets overall.

While all types of dialysis are still growing in numbers, the market share increase per new patient is the lowest for in-center hemodialysis. The AV fistula and AV fistula needle market are the fastest growing markets as the Fistula First Breakthrough Initiative gains more traction and more medical professionals recommend AV fistulae during hemodialysis initiation for improved results and increased patient safety.

“The main driver for growth of the dialysis device equipment market will be the ever expanding demographic of Americans suffering from end-stage renal disease (ESRD),” explains Dr. Kamran Zamanian, CEO of iData. “As more patients shift to alternative methods of treatment, they help fuel growth of the market.”

The dialysis concentrates market is expected to increase since every dialysis patients uses a great deal of concentrates over the course of a year. As a result, each new patient has a positive multiplier effect on the demand for dialysis concentrates, which will serve to grow the market through 2023. The market will continue to trend toward the use of dry concentrates, which are much easier to ship and less expensive per gallon.

Fresenius, DaVita and U.S. Renal Care are the industry leaders for the provision of dialysis services within the United States. However, Fresenius is the only manufacturer that owns and operates their own clinics utilizing their own equipment and supplies. This has afforded Fresenius an exceptional lead in the U.S. dialysis market. Fresenius offers products in five of the eleven market segments including dialysis machines, dialysis concentrates, dialyzers, AV fistula needles, hemodialysis bloodlines and tubing sets.

Baxter Healthcare is the second leading competitor in the U.S. dialysis market. Baxter offers products in the same segments as Fresenius due to their acquisition of Gambro AG in September 2013 which fueled the company’s market share and greatly strengthened their stance in the U.S. and global dialysis market. Baxter is also a distributor of Rockwell medical’s dialysis concentrates. Additional competitors in the dialysis device market include Medivators, Mar Cor, B. Braun, Medcomp, Medisystems and Teleflex Medical among others.

For Further Information
More on the dialysis device market in the U.S. can be found in a series of reports published by iData Research entitled the US Market Report Suite for Dialysis Devices and Concentrates. The suite covers reports on the following markets: hemodialysis and peritoneal dialysis machines, dialysis catheters, dialyzers, dialyzer reprocessing machines, hemodialysis bloodline and tubing sets, AV fistula needles, AV access grafts, declotting devices, introducer sheaths and guidewires and water treatment systems.

The iData report series on hearing devices covers the U.S. and Canada. Reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about dialysis device market data or procedure data, register online or email us at [email protected] for a US Market Report Suite for Dialysis Device and Concentrates brochure and synopsis.

About iData Research
iData Research ( is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Dental Operatory Equipment, X-Ray Imaging, Vascular Access, Peripheral Vascular, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Diagnostic Imaging, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Oncology, Ultrasound, Laparoscopy, Urology, Gynecology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large and Small Joints, Anesthesiology, Wound Management, Orthopedics, Ophthalmics and more.

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.

Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook:
Follow us on LinkedIn:
Follow us on Twitter: